Modulatory effects of rutin on the expression of cytochrome P450s and antioxidant enzymes in human hepatoma cells

1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent and A. Jemal, Global cancer statistics, 2012, Cancer J. Clin. 65 (2015) 87-108; DOI: 10.3322/caac.21262.10.3322/caac.21262Search in Google Scholar

2. M. Balbi, V. Donadon, M. Ghersetti, S. Grazioli, G. D. Valentina, R. Gardenal, M. D. Mas, P. Casarin, G. Zanette, C. Miranda and P. Cimarosti, Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy, Int. J. Environ. Res. Public Health 7 (2010) 1366-1378; DOI: 10.3390/ijerph7041366.10.3390/ijerph7041366Search in Google Scholar

3. X. Zhang and H. G. Ding, Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinoma, World J. Hepatol. 7 (2015) 1282-1286; DOI: 10.4254/wjh.v7.i9.1282.10.4254/wjh.v7.i9.1282Search in Google Scholar

4. P. C. Hollman and M. B. Katan, Absorption, metabolism and health effects of dietary flavonoids in man, Biomed. Pharmacother. 51 (1997) 305-310; DOI: 10.1016/S0753-3322(97)88045-6.10.1016/S0753-3322(97)88045-6Search in Google Scholar

5. E. Middleton, C. Kandaswami and T. C. Theoharides, The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev. 52 (2000) 673-751.Search in Google Scholar

6. G. Williamson and C. Manach, Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies, Am. J. Clin. Nutr. 81 (2005) 243S-255S.Search in Google Scholar

7. B. A. Graf, C. Ameho, G. G. Dolnikowski, P. E. Milbury, C. Y. Chen and J. B. Blumberg, Rat gastrointestinal tissues metabolize quercetin, J. Nutr. 136 (2006) 39-44.10.1093/jn/136.1.3916365056Search in Google Scholar

8. S. Scholz and G. Williamson, Interactions affecting the bioavailability of dietary polyphenols in vivo, Int. J. Vitam. Nutr.Res. 77 (2007) 224-235; DOI: 10.1024/0300-9831.77.3.224.10.1024/0300-9831.77.3.22418214024Search in Google Scholar

9. V. A. Kostyuk, A. I. Potapovich, T. V. Kostyuk and M. G. Cherian, Metal complexes of dietary flavonoids: evaluation of radical scavenger properties and protective activity against oxidative stress in vivo, Cell. Mol. Biol. (Noisy-le-grand) 53 (2007) 62-69; DOI: 10.1170/T776.Search in Google Scholar

10. K. Song, J. Y. Na, S. Kim and J. Kwon, Rutin upregulates neurotrophic factors resulting in attenuation of ethanol-induced oxidative stress in HT22 hippocampal neuronal cells, J. Sci. Food Agric. 95 (2015) 2117-2123; DOI: 10.1002/jsfa.6927.10.1002/jsfa.692725251136Search in Google Scholar

11. B. L. Santos, A. R. Silva, B. P. Pitanga, C. S. Sousa, M. S. Grangeiro, B. O. Fragomeni, P. L. Coelho, M. N. Oliveira, N. J. Menezes-Filho, M. F. Costa, R. S. El-Bachá, E. S. Velozo, G. P. Sampaio, S. M. Freire, M. Tardy and S. L. Costa, Antiproliferative, proapoptotic and morphogenic effects of the flavonoid rutin on human glioblastoma cells, Food Chem. 127 (2011) 404-411; DOI: 10.1016/j.foodchem. 2010.12.13.Search in Google Scholar

12. N. Ihme, H. Kiesewetter, F. Jung, K. H. Hoffmann, A. Birk, A. Müller and K. I. Grützner, Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single- centre, randomised, double-blind, placebo-controlled clinical trial, Eur. J. Clin. Pharmacol. 50 (1996) 443-447; DOI: 10.1007/s002280050138.10.1007/s0022800501388858269Search in Google Scholar

13. S. Okonogi, R. Khonkarn, S. Mankhetkorn, F. M. Unger and H. Viernstein, Antioxidant activity and cytotoxicity of Cyrtosperma johnstonii extracts on drug sensitive and resistant leukemia and small cell lung carcinoma cells, Pharm. Biol. 51 (2013) 329-338; DOI: 10.3109/13880209.2012.729064.10.3109/13880209.2012.72906423153173Search in Google Scholar

14. H. J. You, H. J. Ahn and G. E. Ji, Transformation of rutin to antiproliferative quercetin-3-glucoside by Aspergillus niger, J. Agric. Food Chem. 58 (2010) 10886-10892; DOI: 10.1021/jf102871g.10.1021/jf102871g20886886Search in Google Scholar

15. F. P. Guengerich, Cytochrome P-450 3A4: regulation and role in drug metabolism, Annu. Rev. Pharmacol. Toxicol. 39 (1999) 1-17; DOI: 10.1146/annurev.pharmtox.39.1.1.10.1146/annurev.pharmtox.39.1.1Search in Google Scholar

16. U. M. Zanger and M. Schwab, Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation, Pharmacol. Ther. 138 (2013) 103-141; DOI: 10.1016/j.pharmthera.2012.12.007.10.1016/j.pharmthera.2012.12.007Search in Google Scholar

17. K. Ohkura, Y. Kawaguchi, Y. Watanabe, Y. Masubuchi, Y. Shinohara and H. Hori, Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket, Anticancer Res. 29 (2009) 935-942.Search in Google Scholar

18. E. Arinç, D. Yilmaz and A. Bozcaarmutlu, Mechanism of inhibition of CYP1A1 and glutathione S-transferase activities in fish liver by quercetin, resveratrol, naringenin, hesperidin, and rutin, Nutr. Cancer 67 (2015) 137-144; DOI: 10.1080/01635581.2015.965335.10.1080/01635581.2015.965335Search in Google Scholar

19. T. Fujimura, S. Takahashi, T. Urano, T. Tanaka, W. Zhang, K. Azuma, K. Takayama, D. Obinata, T. Murata, K. Horie-Inoue, T. Kodama, Y. Ouchi, Y. Homma and S. Inoue, Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer, Cancer Sci. 103 (2012) 176-180; DOI: 10.1111/j.1349-7006.2011.02143.x.10.1111/j.1349-7006.2011.02143.xSearch in Google Scholar

20. J. C. Stevens, R. N. Hines, C. Gu, S. B. Koukouritaki, J. R. Manro, P. J. Tandler and M. J. Zaya, Developmental expression of the major human hepatic CYP3A enzymes, J. Pharmacol. Exp. Ther. 307 (2003) 573-582; DOI: 10.1124/jpet.103.054841.10.1124/jpet.103.054841Search in Google Scholar

21. H. P. Ciolino, P. J. Daschner and G. C. Yeh, Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially, Biochem. J. 340 (1999) 715-722; DOI: 10.1042/bj3400715.10.1042/bj3400715Search in Google Scholar

22. R. Vrba, R. Aujeský and C. Neoral, Results of limited resection of carcinoma of the gastroesophageal junction, Rozhl. Chir. 91 (2012) 368-372.Search in Google Scholar

23. Mohammadi-Bardbori, J. Bengtsson, U. Rannug, A. Rannug and E. Wincent, Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR), Chem. Res. Toxicol. 25 (2012) 1878-1884; DOI: 10.1021/tx300169e. 10.1021/tx300169eSearch in Google Scholar

24. L. Rongrui, H. Na, L. Zongfang, J. Fanpu and J. Shiwen, Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis, Curr. Pharm. Des. 20 (2014) 1715-1725; DOI: 10.2174/13816128113199990533.10.2174/13816128113199990533Search in Google Scholar

25. M. Kiran, Y. K. Chawla and J. Kaur, Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India, Cancer Genet. Cytogenet. 195 (2009) 112-119; DOI: 10.1016/j.cancergencyto.2009.06.021.10.1016/j.cancergencyto.2009.06.021Search in Google Scholar

26. D. Ross, J. K. Kepa, S. L. Winski, H. D. Beall, A. Anwar and D. Siegel, NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms, Chem. Biol. Interact. 129 (2000) 77-97; DOI: 10.1016/S0009-2797(00)00199-X.10.1016/S0009-2797(00)00199-XSearch in Google Scholar

27. P. Joseph, T. Xie, Y. Xu and A. K. Jaiswal, NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer, Oncol. Res. 6 (1994) 525-532.Search in Google Scholar

28. E. A. Rosvold, K. A. McGlynn, E. D. Lustbader and K. H. Buetow, Identification of an NAD(P) H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking, Pharmacogenetics 5 (1995) 199-206.Search in Google Scholar

29. Y. Fan, D. Hu, B. Feng and W. Wang, The NQO1 C609T polymorphism and hepatocellular carcinoma risk, Tumour Biol. 35 (2014) 7343-7350; DOI: 10.1007/s13277-014-1712-8.10.1007/s13277-014-1712-824532470Search in Google Scholar

30. H. Akkiz, S. Bayram, A. Bekar, E. Akgöllü, Y. Ülger, B. Y. Kaya, M. Sandikçi and B. Özdil, No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects, Asian Pac. J. Cancer Prev. 11 (2010) 1051-1058.Search in Google Scholar

31. M. Belinsky and A. K. Jaiswal, NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues, Cancer Metastasis Rev. 12 (1993) 103-117; DOI: 10.1007/BF00689804 10.1007/BF006898048375015Search in Google Scholar